Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | XIAP | P98170 | 1/20 | 0.52 |
| ▸ | ENPEP | Q07075 | 5/20 | 0.45 |
| ▸ | NPY1R | P25929 | 2/20 | 0.44 |
| ▸ | NTSR2 | O95665 | 1/20 | 0.44 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.44 |
| ▸ | F2 | P00734 | 4/20 | 0.44 |
| ▸ | ACE | P12821 | 2/20 | 0.43 |
| ▸ | REN | P00797 | 1/20 | 0.43 |
| ▸ | GRB2 | P62993 | 1/20 | 0.42 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31235878 | 0.91 | NTSR1 (0.48) | XIAPNPY1RNTSR2NTSR1F2 | |
| SCHEMBL31235876 | 0.91 | NTSR1 (0.48) | XIAPNPY1RNTSR2NTSR1F2 | |
| SCHEMBL31235886 | 0.89 | XIAP (0.45) | XIAPNPY1RNTSR2NTSR1F2 | |
| SCHEMBL31235872 | 0.88 | XIAP (0.46) | XIAPNPY1RF2OPRM1 | |
| SCHEMBL29352327 | 0.87 | XIAP (0.55) | XIAPACERENGRB2 | |
| SCHEMBL29870992 | 0.87 | XIAP (0.55) | XIAPACERENGRB2 | |
| SCHEMBL31747054 | 0.87 | XIAP (0.57) | XIAPACERENGRB2OPRM1 | |
| SCHEMBL30532202 | 0.86 | XIAP (0.53) | XIAPENPEPNTSR2NTSR1F2 | |
| SCHEMBL29452627 | 0.85 | XIAP (0.50) | XIAPNPY1RNTSR2NTSR1GRB2 | |
| SCHEMBL31235877 | 0.85 | NPY1R (0.52) | NPY1RNTSR2NTSR1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116903699-A | NIR-II region fluorescent probe for granzyme B detection, and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-10-20 | — | — | CN | claimed |
| CN-114107435-A | Activatable photoacoustic-fluorescence dual-mode probe for real-time monitoring of immunotherapy and application | 广东省人民医院 | 2022-03-01 | — | — | CN | claimed |
| EP-4733324-A2 | METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT | ATB Therapeutics (BE) | 2026-04-29 | — | — | EP | disclosed |
| US-20250346648-A1 | MAGE A4 T CELL RECEPTORS | MEDIGENE IMMUNOTHERAPIES GMBH (DE) | 2025-11-13 | — | — | US | disclosed |
| EP-3927831-B1 | METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT | ATB THERAPEUTICS (BE) | 2025-11-12 | — | — | EP | disclosed |
| EP-4631516-A2 | MAGE A4 T CELL RECEPTORS | Medigene Immunotherapies GmbH (DE) | 2025-10-15 | — | — | EP | disclosed |
| US-12344654-B2 | Mage A4 T cell receptors | MEDIGENE IMMUNOTHERAPIES GMBH (DE) | 2025-07-01 | — | — | US | disclosed |
| EP-3946621-B1 | MAGE A4 T CELL RECEPTORS | MEDIGENE IMMUNOTHERAPIES GMBH (DE) | 2025-05-21 | — | — | EP | disclosed |
| US-20240376517-A1 | GRANZYME B DETECTION | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2024-11-14 | — | — | US | disclosed |
| EP-4352076-A1 | GRANZYME B DETECTION | The University Court Of The University of Edinburgh (GB) | 2024-04-17 | — | — | EP | disclosed |
| CN-116903699-A | NIR-II region fluorescent probe for granzyme B detection, and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2023-10-20 | — | — | CN | disclosed |
| US-20230203108-A1 | IMPROVED GRANZYME B VARIANT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-06-29 | — | — | US | disclosed |
| US-20230159612-A1 | MAGE A4 T CELL RECEPTORS | REGENERON PHARMACEUTICALS, INC. | 2023-05-25 | — | — | US | disclosed |
| CN-115925972-A | Method for producing conjugate-toxin fusion proteins in plant cells or whole plants | ATB治疗公司 | 2023-04-07 | — | — | CN | disclosed |
| EP-4159237-A1 | IMPROVED GRANZYME B VARIANT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-04-05 | — | — | EP | disclosed |
| WO-2022258997-A1 | GRANZYME B DETECTION | THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH (GB) | 2022-12-15 | — | — | WO | disclosed |
| CN-113728107-B | Method for producing conjugate-toxin fusion proteins in plant cells or whole plants | ATB治疗公司 | 2022-06-24 | — | — | CN | disclosed |
| US-20220090113-A1 | METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT | ATB THERAPEUTICS (BE) | 2022-03-24 | — | — | US | disclosed |
| CN-114107435-A | Activatable photoacoustic-fluorescence dual-mode probe for real-time monitoring of immunotherapy and application | 广东省人民医院 | 2022-03-01 | — | — | CN | disclosed |
| CN-114126716-A | MAGE A4T cell receptor | 基因医疗免疫疗法有限责任公司 | 2022-03-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220090113-A1 | METHOD OF PRODUCING A BINDER-TOXIN FUSION PROTEIN IN A PLANT CELL OR A WHOLE PLANT | MAX, PHAX, TIAL1 | XIAP 1534/4885ENPEP 955/4885NPY1R 3994/4885 |
| US-20240376517-A1 | GRANZYME B DETECTION | GZMB, CTSB, DNASE1L3 | XIAP 598/4885ENPEP 52/4885NPY1R 1620/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.